(Q53049522)

10 May 2018

title

Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. (English)

1 reference

10 May 2018

14

Atsushi Iwama

1 reference

10 May 2018

author name string

Tetsuhiro Chiba

1

1 reference

10 May 2018

Tomoko Saito

2

1 reference

10 May 2018

Kaori Yuki

3

1 reference

10 May 2018

Yoh Zen

4

1 reference

10 May 2018

Shuhei Koide

5

1 reference

10 May 2018

Naoya Kanogawa

6

1 reference

10 May 2018

Tenyu Motoyama

7

1 reference

10 May 2018

Sadahisa Ogasawara

8

1 reference

10 May 2018

Eiichiro Suzuki

9

1 reference

10 May 2018

Yoshihiko Ooka

10

1 reference

10 May 2018

Akinobu Tawada

11

1 reference

10 May 2018

Masayuki Otsuka

12

1 reference

10 May 2018

Masaru Miyazaki

13

1 reference

10 May 2018

Osamu Yokosuka

15

1 reference

10 May 2018

language of work or name

English

0 references

publication date

30 May 2014

1 reference

10 May 2018

International Journal of Cancer

published in

1 reference

10 May 2018

volume

136

1 reference

10 May 2018

issue

2

1 reference

10 May 2018

page(s)

289-298

1 reference

10 May 2018

Cancer epigenetics: from mechanism to therapy

cites work

1 reference

21 January 2018

Epigenetics in cancer

1 reference

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers

21 January 2018

1 reference

Regulation of chromatin by histone modifications

21 January 2018

1 reference

Polycomb silencers control cell fate, development and cancer

21 January 2018

1 reference

Stem cells and cancer; the polycomb connection

21 January 2018

1 reference

Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma

21 January 2018

1 reference

3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells

21 January 2018

1 reference

Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly

21 January 2018

1 reference

The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma

21 January 2018

1 reference

Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo.

21 January 2018

1 reference

Regulation of chromatin structure by site-specific histone H3 methyltransferases

21 January 2018

1 reference

Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability

21 January 2018

1 reference

SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins

21 January 2018

1 reference

The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset

21 January 2018

1 reference

Histone H3-K9 methyltransferase ESET is essential for early development

21 January 2018

1 reference

A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex.

21 January 2018

1 reference

The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells

21 January 2018

1 reference

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

21 January 2018

1 reference

Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b

21 January 2018

1 reference

Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats

21 January 2018

1 reference

Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice

21 January 2018

1 reference

mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression

21 January 2018

1 reference

Role of histone lysine methyltransferases SUV39H1 and SETDB1 in gliomagenesis: modulation of cell proliferation, migration, and colony formation

21 January 2018

1 reference

Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis

21 January 2018

1 reference

Cancer epigenomics: DNA methylomes and histone-modification maps

21 January 2018

1 reference

Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9.

21 January 2018

1 reference

On the histone lysine methyltransferase activity of fungal metabolite chaetocin.

21 January 2018

1 reference

Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A.

21 January 2018

1 reference

Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition

21 January 2018

1 reference

Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer.

21 January 2018

1 reference

Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1α pre-mRNA in mice and in vitro.

21 January 2018

1 reference

[Isolation and configuration of Chaetocin]

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/HLCA.19700530521

9 March 2024

Identifiers

DOI

10.1002/IJC.28985

1 reference

10 May 2018

1 reference

10 May 2018